GALZIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Galzin, and when can generic versions of Galzin launch?
Galzin is a drug marketed by Teva and is included in one NDA.
The generic ingredient in GALZIN is zinc acetate. There are thirty-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the zinc acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GALZIN?
- What are the global sales for GALZIN?
- What is Average Wholesale Price for GALZIN?
Summary for GALZIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Clinical Trials: | 1 |
Drug Prices: | Drug price information for GALZIN |
What excipients (inactive ingredients) are in GALZIN? | GALZIN excipients list |
DailyMed Link: | GALZIN at DailyMed |
Recent Clinical Trials for GALZIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
American Lung Association | Phase 2 |
Johns Hopkins University | Phase 2 |
National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
Pharmacology for GALZIN
Drug Class | Copper Absorption Inhibitor |
Physiological Effect | Decreased Copper Ion Absorption |
US Patents and Regulatory Information for GALZIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | GALZIN | zinc acetate | CAPSULE;ORAL | 020458-001 | Jan 28, 1997 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | GALZIN | zinc acetate | CAPSULE;ORAL | 020458-002 | Jan 28, 1997 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |